Assembly Biosciences, Inc. (ASMB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 8.21M | 42.47M | 10.79M | 9.63M | 9.42M | 7.36M | 6.84M | 8.53M | 5.79M | 7.16M | 0 | 0 |
| Revenue Growth % | -12.8% | 477.26% | 57.62% | 12.81% | 62.82% | 2.71% | - | - | - | - | - | - |
| Cost of Goods Sold | 26K | 32K | 0 | 16.13M | 0 | 14.28M | 0 | 32K | 32K | 84K | 10.82M | 12.52M |
| COGS % of Revenue | 0.32% | 0.08% | - | 167.52% | - | 194.1% | - | 0.38% | 0.55% | 1.17% | - | - |
| Gross Profit | 8.19M | 42.44M | 10.79M | -6.5M | 9.42M | -6.92M | 6.84M | 8.5M | 5.75M | 7.08M | -10.82M | -12.52M |
| Gross Margin % | 99.68% | 99.92% | 100% | -67.52% | 100% | -94.1% | 100% | 99.63% | 99.45% | 98.83% | - | - |
| Gross Profit Growth % | -13.08% | 712.99% | 57.62% | -176.45% | 63.72% | -197.8% | 163.24% | 167.88% | 139.55% | 141.03% | 37.9% | 27.58% |
| Operating Expenses | 19.58M | 22.67M | 21.67M | 4.59M | 19.36M | 4.61M | 17.8M | 20.7M | 16.48M | 19.63M | 4.22M | 4.96M |
| OpEx % of Revenue | 238.44% | 53.38% | 200.87% | 47.72% | 205.54% | 62.65% | 260.06% | 242.63% | 284.91% | 274.05% | - | - |
| Selling, General & Admin | 4.68M | 5.42M | 5.08M | 4.59M | 4.51M | 4.61M | 4.29M | 4.45M | 4.6M | 8.62M | 4.22M | 4.96M |
| SG&A % of Revenue | 57.02% | 12.76% | 47.13% | 47.72% | 47.87% | 62.65% | 62.61% | 52.09% | 79.57% | 120.4% | - | - |
| Research & Development | 14.9M | 17.25M | 16.59M | 16.13M | 14.85M | 14.28M | 13.52M | 16.26M | 11.88M | 11.01M | 10.82M | 12.52M |
| R&D % of Revenue | 181.42% | 40.62% | 153.74% | 167.52% | 157.67% | 194.1% | 197.44% | 190.54% | 205.34% | 153.65% | - | - |
| Other Operating Expenses | 0 | 0 | 0 | -1000K | 0 | -1000K | 0 | 0 | 0 | 0 | -1000K | -1000K |
| Operating Income | -11.37M | 19.8M | -10.88M | -11.09M | -9.94M | -11.53M | -10.96M | -12.2M | -10.73M | -12.55M | -15.05M | -17.49M |
| Operating Margin % | -138.44% | 46.62% | -100.87% | -115.24% | -105.54% | -156.75% | -160.06% | -143.01% | -185.46% | -175.22% | - | - |
| Operating Income Growth % | -14.37% | 271.69% | 0.67% | 9.1% | 7.34% | 8.12% | 27.19% | 30.22% | 45.15% | 45.38% | 35.7% | 28.83% |
| EBITDA | -11.34M | 19.83M | -10.85M | -11.06M | -9.91M | -11.5M | -10.92M | -12.17M | -10.7M | -12.47M | -14.93M | -17.36M |
| EBITDA Margin % | -138.12% | 46.7% | -100.57% | -114.91% | -105.19% | -156.31% | -159.58% | -142.63% | -184.91% | -174.05% | - | - |
| EBITDA Growth % | -14.49% | 272.44% | 0.66% | 9.12% | 7.38% | 7.76% | 26.85% | 29.9% | 44.96% | 45.45% | 35.82% | 29% |
| D&A (Non-Cash Add-back) | 26K | 32K | 32K | 32K | 33K | 32K | 33K | 32K | 32K | 84K | 116K | 126K |
| EBIT | -11.37M | 19.8M | -9.2M | -11.09M | -9.94M | -11.53M | -10.96M | -12.2M | -10.73M | -12.55M | -15.05M | -17.49M |
| Net Interest Income | 2.29M | 2.29M | 1.69M | 895K | 1.12M | 1.12M | 1.34M | 1.46M | 1.65M | 1.62M | 628K | 592K |
| Interest Income | 2.29M | 2.29M | 1.69M | 895K | 1.12M | 1.12M | 1.34M | 1.46M | 1.65M | 1.62M | 628K | 592K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.29M | 2.29M | 1.69M | 895K | 1.12M | 1.27M | 1.34M | 1.46M | 1.65M | 1.62M | 628K | 592K |
| Pretax Income | -9.08M | 22.09M | -9.2M | -10.2M | -8.82M | -10.26M | -9.61M | -10.75M | -9.08M | -10.93M | -14.42M | -16.9M |
| Pretax Margin % | -110.54% | 52.01% | -85.23% | -105.94% | -93.62% | -139.45% | -140.44% | -125.93% | -156.91% | -152.58% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 76K | 0 | 406K | 0 | 33K | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -0.74% | 0% | -3.78% | 0% | -0.3% | 0% | 0% |
| Net Income | -9.08M | 22.09M | -9.2M | -10.2M | -8.82M | -10.34M | -9.61M | -11.15M | -9.08M | -10.96M | -14.42M | -16.9M |
| Net Margin % | -110.54% | 52.01% | -85.23% | -105.94% | -93.62% | -140.48% | -140.44% | -130.69% | -156.91% | -153.04% | - | - |
| Net Income Growth % | -2.96% | 313.74% | 4.34% | 8.55% | 2.85% | 5.72% | 33.34% | 34% | 52.1% | 51.05% | 37.7% | 30.93% |
| Net Income (Continuing) | -9.08M | 22.09M | -9.2M | -10.2M | -8.82M | -10.34M | -9.61M | -11.15M | -9.08M | -10.96M | -14.42M | -16.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.54 | 2.49 | -1.20 | -1.33 | -1.17 | -1.72 | -1.51 | -1.98 | -1.66 | -2.00 | -3.29 | -3.88 |
| EPS Growth % | 53.85% | 244.77% | 20.53% | 32.83% | 29.52% | 14% | 54.1% | 48.97% | 61.48% | 62.41% | 30% | 22.4% |
| EPS (Basic) | -0.54 | 2.49 | -1.20 | -1.33 | -1.17 | -1.72 | -1.51 | -1.98 | -1.66 | -2.00 | -3.29 | -3.88 |
| Diluted Shares Outstanding | 16.9M | 11.21M | 7.66M | 7.66M | 7.51M | 6.58M | 6.35M | 5.64M | 5.48M | 5.48M | 4.38M | 4.36M |
| Basic Shares Outstanding | 16.9M | 11.21M | 7.66M | 7.66M | 7.51M | 6.58M | 6.35M | 5.64M | 5.48M | 5.48M | 4.38M | 4.36M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |